Treatment of migraine [3] (multiple letters)

New England Journal of Medicine

Volumn 347, Issue 10, 2002, Pages 764-766

  Werner, Arnold ^a   Wyderski, Richard J ^a   Samuels, Noah ^a   Barker, Juliet N ^a   Ewart, Robert M ^a   Klein, Arnold W ^a   Goadsby, Peter J ^a   Lipton, Richard B ^a   Ferrari, Michael D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BOTULINUM TOXIN A; CAFFEINE; CODEINE; LYSINE ACETYLSALICYLATE; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIBAVIRIN; SUMATRIPTAN; MUSCLE RELAXANT AGENT; TRYPTOPHAN; ACETYLSALICYLIC ACID LYSINATE; ANALGESIC AGENT; DRUG DERIVATIVE; LYSINE; RIBOFLAVIN; SEROTONIN AGONIST;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HEADACHE; HUMAN; LETTER; META ANALYSIS; MIGRAINE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; NOTE; METHODOLOGY; CHEMICALLY INDUCED DISORDER; ACUPUNCTURE;

BOTULINUM TOXIN TYPE A; HUMANS; MIGRAINE DISORDERS; NEUROMUSCULAR AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; PLACEBOS; TRYPTOPHAN; ANALGESICS; ASPIRIN; LYSINE; METOCLOPRAMIDE; RIBOFLAVIN; SEROTONIN AGONISTS; SUMATRIPTAN; ANALGESICS, OPIOID; CAFFEINE; ACUPUNCTURE THERAPY;

EID: 0037026370     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200209053471016     Document Type: Letter

References (0)